News & Research

Hyperbaric Oxygen Therapy has been used for the better part of two centuries. Search our  arhives below for past HBOT news and research or scroll down for the latest.

The Latest HBOT News & Research

Radionecrosis 30 years after breast cancer.

Abstract: This report describes the case of a 70-year-old woman presenting to outpatient with a several-week history of a painful mass in her right breast, 30 years after her treatment for primary breast cancer. At first, this was suspected to have...

Clinical Trial – Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment

By doing this study, researchers hope to learn the following:

– If providing hyperbaric oxygen (HBO) therapy prior to an umbilical cord blood (UBC)
transplant will help to improve the homing process

– The safety of HBO administration in the setting of the UBC transplant

– The effects of HBO therapy on the engraftment process

Clinical Trial – Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.

There is a wide variability of options for treatment of chronic radiation proctitis. However,
studies are still limited, usually case reports from a single center and few are comparative
studies between methods. Therefore, the choice of treatment is determined by availability and
local expertise for each method. The variability of treatment options range from
anti-inflammatory medical treatment, sucralfate, short chain fatty acids, antioxidants and
hyperbaric oxygen to such endoscopic and surgical treatments. Surgery is usually the last
therapeutic option due to the high morbidity and mortalityassociated. Various endoscopic
treatment modalities have been reported. Formalin topic is effective in up to 48% of patients
with chronic radiation proctitis.

The endoscopic treatment with argon plasma (APC) is low cost, easy to apply and
transportation, safe and effective in the treatment of rectal bleeding in patients with
chronic radiation proctitis. Currently, the APC is the preferred endoscopic modality.

Most studies on the use of APC in radiation proctitis showed benefit. The APC controls the
mild to moderate rectal bleeding in 80% to 90% of cases and improves symptoms of urgency,
diarrhea and tenesmus in 60% to 75% of cases.